AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Rogers Communications Raises Price Target to $33.00 Amidst Optimism for Future Performance
ByAinvest
Tuesday, Aug 12, 2025 7:48 pm ET1min read
Alvotech is set to release its quarterly earnings on August 13, 2025. Analysts expect an earnings per share (EPS) of $-0.11. The company's past performance has shown that guidance can be a key determinant of stock price movements. Alvotech's shares are trading at $8.52, down 21.99% over the last 52-week period. Long-term shareholders are likely bearish going into this earnings release.
Alvotech (NASDAQ: ALVO), a global biotech company focused on developing and manufacturing biosimilar medicines, is set to release its second-quarter (Q2) 2025 financial results on August 13, 2025, after U.S. markets close. The earnings announcement is eagerly anticipated by investors, who will be closely monitoring the company's performance and guidance for the period.Analysts expect Alvotech to report an earnings per share (EPS) of $-0.11 for the quarter. The company's past performance indicates that guidance can significantly influence stock price movements. During the last quarter, Alvotech reported an EPS that missed estimates by $0.07, leading to a 18.14% increase in the share price on the subsequent day [1].
Alvotech's shares are currently trading at $8.52, down 21.99% over the last 52-week period. The negative returns have likely made long-term shareholders bearish going into this earnings release. The company has a robust pipeline with nine biosimilar candidates in development, targeting various medical conditions, and has established strategic partnerships globally to enhance its market presence [2].
Following the earnings announcement, Alvotech will host a conference call on August 14, 2025, at 8:00 am EDT (12:00 noon GMT, 14:00 CET) to discuss the results and recent business highlights. The webcast and conference call will be available on Alvotech's investor portal [3].
References:
[1] https://www.benzinga.com/insights/earnings/25/08/47063079/alvotechs-earnings-a-preview
[2] https://www.quiverquant.com/news/Alvotech+to+Release+First+Half+2025+Financial+Results+on+August+13%2C+Conference+Call+Scheduled+for+August+14
[3] https://www.ainvest.com/news/alvotech-reports-q2-2025-earnings-webcast-conference-call-set-august-14-2508/
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet